SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,224.60 |
| Enterprise Value ($M) | 4,836.01 |
| Book Value ($M) | -1,054.35 |
| Book Value / Share | -13.67 |
| Price / Book | -3.06 |
| NCAV ($M) | -1,883.23 |
| NCAV / Share | -24.42 |
| Price / NCAV | -1.71 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.60 |
| Current Ratio | 1.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,013.36 |
| Assets | 1,842.24 |
| Liabilities | 2,896.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.40 | 5.40 | |
| 13G/A | Wellington Management Group Llp | 10.26 | -19.60 | |
| 13G/A | State Street Corp | 3.80 | -37.44 | |
| 13G/A | Rtw Investments, Lp | 9.80 | 32.21 | |
| 13G/A | Vanguard Group Inc | 11.66 | 19.91 | |
| 13G/A | Fmr Llc | 2.40 | -71.79 | |
| 13G/A | BlackRock, Inc. | 10.20 | 15.48 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 71,551 | 411,227 | 17.40 | |
| 81,378 | 728,404 | 11.17 | |
| 101,458 | 495,825 | 20.46 | |
| 65,403 | 439,399 | 14.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRAX – Praxis Precision Medicines, Inc. | PRLD – Prelude Therapeutics Incorporated |
| PRTA – Prothena Corporation plc | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation |
Financial data and stock pages provided by
Fintel.io